Skip to search formSkip to main contentSkip to account menu

1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Recombivax]

Known as: Recombivax HB, Hepatitis B vaccine (recombinant) Dialysis Formulation 40 MCG per 1 ML Injection, 1 ML Recombivax 0.04 MG/ML Injection, Recombivax HB 40 MCG per 1 ML Injection 
National Institutes of Health

Related topics

Related topics

3 relations
Hepatitis B Surface Antigen VaccineInjectionRecombivax

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B.
UNLABELLED Recombinant hepatitis B vaccine Engerix B((R)) [Hep-B(Eng)] is a noninfectious subunit hepatitis B viral vaccine… 
Highly Cited
1996
Highly Cited
1996
Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.
1990
1990
Safety and immunogenicity of a recombinant hepatitis B vaccine in patients infected with Schistosoma mansoni.
Thirty Egyptian males, 8-31 years of age, with active Schistosoma mansoni infection and negative serologic tests for hepatitis B… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)